Biologic medicines have revolutionized the treatment of many serious disorders. Biosimilars offer similar safety and efficacy at a fraction of the cost, though

Biosimilars have been in clinical use for more than 10 years, and evidence from more than 700 million patient-days’ exposure shows that approved biosimilars c

Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical

Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical

Psoriasis can no longer be considered a mere skin disease - it is a spectrum of different conditions requiring a spectrum of different treatments. Yet the syste